BPG is committed to discovery and dissemination of knowledge
Citation
Pan J, Li P, Zhao Y, Zhou YH, Zhao Y, Zhang TL, Chen YT, Chu XY. Efficacy and safety of fruquintinib plus sintilimab in third-line treatment of metastatic colorectal cancer: A single-center experience. World J Gastrointest Oncol 2026; 18(6): 117101 [DOI: 10.4251/wjgo.v18.i6.117101]
Please LOGIN to submit a new comment.